Skip to main content
. 2024 Mar 4;15:1322557. doi: 10.3389/fphar.2024.1322557

TABLE 2.

Summary of the ORIN1001 pharmacokinetic parameters calculated using the non-compartmental analysis (NCA).

Dose (mg) AUC0-t a , b (ng·h/mL) AUC0-inf a (ng·h/mL) Cmax a (ng/mL) Tmax c (h) t1/2 a (h) Vz/F a (L) CL/F a (L/h)
Single-dose 100 (n = 3) 68788.93 (11862.47) 75962.73 (13066.34) 3820 (663.67) 2 (2,2) 33.26 (6.66) 64.02 (14.63) 1.34 (0.22)
200 (n = 3) 131728.83 (7053.45) 145145.68 (10518.25) 5590 (1,092.34) 7.33 (4,12) 32.01 (1.36) 63.74 (2.71) 1.38 (0.10)
300 (n = 4) 228262.75 (40115.46) 255482.73 (43998.63) 9360 (1947.67) 4 (2,6) 32.03 (2.65) 56.10 (14.76) 1.20 (0.22)
400 (n = 3) 368183.33 (134885.27) 429240.23 (187717.63) 13446.67 (3589.78) 4 (4,4) 33.68 (8.52) 48.56 (14.41) 1.05 (0.43)
500 (n = 3) 378935.33 (11038.56) 423552.73 (9794.66) 14866.67 (2182.51) 4.33 (1,6) 33.46 (5.25) 57.01 (9.18) 1.18 (0.03)
650 (n = 5) 522604.40 (160299.01) 577313.57 (191065.33) 18300 (1826.20) 5.60 (2,12) 29.74 (4.81) 51.51 (14.21) 1.24 (0.43)
900 (n = 4) 1043135 (389883.52) 1188790.39 (477250.87) 31225 (9468.32) 11.50 (6,24) 33.90 (3.82) 43.46 (23.54) 0.90 (0.48)
Multiple- dose 100 (n = 3) 66065 (7377.35) 4846.67 (226.79) 3.33 (2,4) 16.05 (5.98) 20.85 (1.68) 0.99 (0.35)
200 (n = 3) 171946.67 (33840.18) 10633.33 (650.64) 4.67 (2,8) 20.19 (4.41) 18.65 (2.44) 0.67 (0.23)
300 (n = 3) 239481.67 (52023.15) 14700 (3459.77) 4 (2,6) 21.25 (2.61) 20.64 (3.97) 0.68 (0.19)
400 (n = 3) 371281.67 (95066.09) 21466.67 (4781.56) 4 (2,6) 25.53 (8.60) 18.76 (4.12) 0.55 (0.23)
500 (n = 3) 579450 (201502.75) 33533.33 (10802.93) 4.33 (1,8) 31.04 (9.63) 16.37 (4.96) 0.40 (0.19)
650 (n = 2) 661975 39400 2 (2,2) 18.91 16.29 0.59
900 (n = 2) 1022700 58650 5 (4,6) 17.81 14.73 0.57
a

These data are displayed as mean (SD).

b

t means the time points at 100 h after single-dose and 24 h after multiple-dose on day 21.

c

Tmax is displayed as median (minimum, maximum).